Evidence map›Paper›PMID 42890233›Full record

ArticleFrontiers in immunology2026

Peripheral immune profiles separate disease activity stages in birdshot uveitis.

D Pohlmann-Krappitz, I Kaeferstein, B Kruse, S Winterhalter, A Thiel, U Pleyer, J Braun

Abstract read
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

D Pohlmann-Krappitz *Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
I Kaeferstein *Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
B KruseBIH Center of Immunomics, BIH, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
S WinterhalterDepartment of Ophthalmology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
A ThielBIH Center of Immunomics, BIH, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
U PleyerBerlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
J BraunBIH Center of Immunomics, BIH, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Birdshot uveitis (BU) is a chronic, debilitating posterior uveitis strongly associated with HLA-A*29, supporting a suspected autoimmune etiology. We used high-dimensional mass cytometry and clinical stratification to characterize the peripheral immune landscape in BU and identify disease activity-dependent signatures. Methods: In this cross-sectional study, we included 36 treated BU patients and 31 age- and sex-matched healthy controls (HCs). All participants underwent comprehensive ophthalmologic evaluation with multimodal imaging. Patients were stratified by an expert ophthalmologist into Inactive, Active, and Burned-out disease activity groups based on clinical and imaging findings. Peripheral blood and serum were collected for immunoprofiling using a 37-marker mass cytometry panel and multiplex cytokine analysis. Results: Compared with HCs, BU patients showed increased frequencies of Th17 cells, CD146 Discussion: Integrated peripheral immune profiling with clinical stratification revealed distinct disease activity-dependent and treatment-associated signatures in BU. Inactive and Burned-out patients showed predominantly exhausted or anergic T cell phenotypes, whereas active disease featured heightened T cell activation and mature NK cell expansion. These findings demonstrate both the value and challenges of interpreting immune profiles in treated patients, especially with biologics such as tocilizumab that alter receptor detectability. Despite the heterogeneity typical of rare-disease cohorts, activity-associated immune patterns were detectable. Future studies should evaluate the diagnostic, prognostic, and monitoring utility of these signatures in BU.

Indexed as

UveitisAdultBiomarkersBirdshot ChorioretinopathyCross-Sectional StudiesCytokinesFemaleHumansImmunophenotypingKiller Cells, NaturalMaleMiddle AgedT-Lymphocyte SubsetsBiomarkersCytokinesbirdshot uveitismass cytometryperipheral immune signaturesT cellsuveitis posterior

Identifiers

PMID42890233
PMCPMC13672581

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.